Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogen-reduction systems for blood components: the current position and future trends.

Jerard Seghatchian1, Gracinda de Sousa

  • 1Blood Components/Apheresis Technologies and Thrombosis/Haemostasis Consultancy, 50 Primrose Hill Road, London NW3 3AA England, UK. jseghatchian@btopenworld.com

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
|November 18, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A personalized view on how artificial intelligence will change the future of multidirectional cell therapy: From design and engineering foundation to some healthcare applications.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same author

What's happening? Editorial comment: Insights on artificial intelligence, cell therapy and stem cell transplantation safety.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same author

An in-depth synthetic wrap on the immune-hemostatic axis in human disease.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same author

Editorial comments: Human Defence Mechanism. Platelet and Red Cell Washing.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same author

Editorial Commentary - From concepts to outcomes: A brief narrative of perspectives on integrating laboratory innovation to advance understanding of immunothrombosis/thromboinflammation, uncertainty in hemoglobin evaluation, and controversy in ABO incompatibility.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same author

Editorial commentary - Reflections on integrating some rapidly evolving essential developments into blood transfusion practice, with fresh eyes on innovation and operational excellence: Current status and future opportunities.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2025

Ensuring blood safety involves advanced pathogen reduction technologies targeting nucleic acids. Methylene blue, psoralen, and riboflavin UV light treatments offer promising alternatives to mitigate transfusion-transmitted infections.

Area of Science:

  • Blood safety and transfusion medicine
  • Infectious disease control
  • Biotechnology and medical device development

Background:

  • Current blood safety measures have significantly reduced viral risks, but bacterial contamination and emerging pathogens remain concerns.
  • The "window period" in infectious disease detection and the inherent risks of using human blood necessitate safer alternatives.
  • Existing mechanical methods like cell washing have limited success against cell-associated agents.

Purpose of the Study:

  • To provide an update on advancements in blood component safety, focusing on pathogen reduction technologies.
  • To review methods targeting pathogen nucleic acids as safer alternatives for blood transfusion.
  • To highlight the comparative aspects of different pathogen inactivation strategies.

Main Methods:

Related Experiment Videos

  • Review of in vitro studies on pathogen nucleic acid targeting methods.
  • Comparison of Methylene Blue Light Treatment (MBLT), Psoralen, and Riboflavin UV light treatments.
  • Evaluation of safety profiles, efficacy against various pathogens, and impact on blood components.

Main Results:

  • Pathogen nucleic acid targeting methods show high safety margins and efficacy in reducing viral load.
  • Methylene blue, psoralen, and riboflavin UV light treatments differ in operational, physicochemical, and biological characteristics.
  • Challenges remain in balancing pathogen reduction benefits with potential effects on blood cell integrity and recipient safety.

Conclusions:

  • Methods targeting pathogen nucleic acids, such as MBLT and PRT systems, represent promising advancements in blood safety.
  • Careful consideration of benefits versus risks, including toxicity and cost-effectiveness, is crucial for implementing new technologies.
  • Further diagnostic procedures are needed to assess the storage stability and functional integrity of treated blood components.